High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial
Article
van Dorp, Jeroen
, Pipinikas, Christodoulos, Suelmann, Britt B. M., Mehra, Niven, van Dijk, Nick
, Marsico, Giovanni, van Montfoort, Maurits L., Hackinger, Sophie, Braaf, Linde M., Amarante, Tauanne, van Steenis, Charlaine, McLay, Kirsten, Daletzakis, Antonios, van den Broek, Daan, van de Kamp, Maaike W., Hendricksen, Kees, de Feijter, Jeantine M., Boellaard, Thierry N., Meijer, Richard P., van der Heijden, Antoine G.
, Rosenfeld, Nitzan, van Rhijn, Bas W. G., Jones, Greg and van der Heijden, Michiel S.
(2023)
High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial.
Nature Medicine 29 (3), pp. 588-592.
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Nature Medicine | ||||
| Publisher | NATURE PORTFOLIO | ||||
| Place of Publication | BERLIN | ||||
| Volume | 29 | ||||
| Number of Issue or Book Chapter | 3 | ||||
| Page Range | pp. 588-592 | ||||
| Date | 2023 | ||||
| Date of publication | 18 Mar 2025 10:10 | ||||
| Institutions | Medicine > Lehrstuhl für Urologie | ||||
| Identification Number |
| ||||
| Keywords | NEOADJUVANT CHEMOTHERAPY; | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 76193 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric